Cargando…

A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse

Increasing evidence links metabolic disorders with neurodegenerative processes including Alzheimer’s disease (AD). Late AD is associated with amyloid (Aβ) plaque accumulation, neuroinflammation, and central insulin resistance. Here, a humanized AD model, the 5xFAD mouse model, was used to further ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Gambero, Antonio J., Rosell-Valle, Cristina, Medina-Vera, Dina, Navarro, Juan Antonio, Vargas, Antonio, Rivera, Patricia, Sanjuan, Carlos, Rodríguez de Fonseca, Fernando, Suárez, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161294/ https://www.ncbi.nlm.nih.gov/pubmed/34065168 http://dx.doi.org/10.3390/ijms22105365

Ejemplares similares

Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity
por: Medina-Vera, Dina, et al.
Publicado: (2020)

Activation of PI3K/Akt Signaling Pathway in Rat Hypothalamus Induced by an Acute Oral Administration of D-Pinitol
por: Medina-Vera, Dina, et al.
Publicado: (2021)

d‐Pinitol promotes tau dephosphorylation through a cyclin‐dependent kinase 5 regulation mechanism: A new potential approach for tauopathies?
por: Medina‐Vera, Dina, et al.
Publicado: (2022)

Novel insights into D-Pinitol based therapies: a link between tau hyperphosphorylation and insulin resistance
por: Medina-Vera, Dina, et al.
Publicado: (2023)

The Biomedical Uses of Inositols: A Nutraceutical Approach to Metabolic Dysfunction in Aging and Neurodegenerative Diseases
por: López-Gambero, Antonio J., et al.
Publicado: (2020)

Pharmacokinetics and Endocrine Effects of an Oral Dose of D-Pinitol in Human Fasting Healthy Volunteers
por: Navarro, Juan A., et al.
Publicado: (2022)

Endocrine and Metabolic Impact of Oral Ingestion of a Carob-Pod-Derived Natural-Syrup-Containing D-Pinitol: Potential Use as a Novel Sweetener in Diabetes
por: Navarro, Juan A., et al.
Publicado: (2022)

Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease
por: Forner, Stefania, et al.
Publicado: (2021)

Preclinical trials in Alzheimer’s disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice
por: Faisal, Mahvish, et al.
Publicado: (2023)

The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats
por: Decara, Juan, et al.
Publicado: (2018)

Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease
por: Wang, Lu, et al.
Publicado: (2016)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
por: Decara, Juan, et al.
Publicado: (2020)

Translational potential of synaptic alterations in Alzheimer’s disease patients and amyloid precursor protein knock-in mice
por: Medina-Vera, Dina, et al.
Publicado: (2023)

Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer’s disease mouse model 5xFAD
por: Boza-Serrano, Antonio, et al.
Publicado: (2018)

Sex-Specific Anxiety and Prefrontal Cortex Glutamatergic Dysregulation Are Long-Term Consequences of Pre-and Postnatal Exposure to Hypercaloric Diet in a Rat Model
por: Rivera, Patricia, et al.
Publicado: (2020)

ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease
por: Sadleir, Katherine R., et al.
Publicado: (2018)

Loss of insulin signaling in astrocytes exacerbates Alzheimer-like phenotypes in a 5xFAD mouse model
por: Chen, Wenqiang, et al.
Publicado: (2023)

The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in App(NL-G-F) Knock-In Mice
por: Medina-Vera, Dina, et al.
Publicado: (2023)

Recombinant IGF-1 Induces Sex-Specific Changes in Bone Composition and Remodeling in Adult Mice with Pappa2 Deficiency
por: Rubio, Leticia, et al.
Publicado: (2021)

Rod pathway and cone pathway retinal dysfunction in the 5xFAD mouse model of Alzheimer’s disease
por: McAnany, J. Jason, et al.
Publicado: (2021)

Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease
por: Landel, Véréna, et al.
Publicado: (2014)

D-Pinitol from Ceratonia siliqua Is an Orally Active Natural Inositol That Reduces Pancreas Insulin Secretion and Increases Circulating Ghrelin Levels in Wistar Rats
por: Navarro, Juan A., et al.
Publicado: (2020)

Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer’s Disease
por: Yang, Eun-Jeong, et al.
Publicado: (2015)

Axonal and myelinic pathology in 5xFAD Alzheimer’s mouse spinal cord
por: Chu, Tak-Ho, et al.
Publicado: (2017)

Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice
por: Shi, Yun, et al.
Publicado: (2020)

Retinal hyperspectral imaging in the 5xFAD mouse model of Alzheimer’s disease
por: Lim, Jeremiah K. H., et al.
Publicado: (2021)

Therapeutic Effects of Aripiprazole in the 5xFAD Alzheimer’s Disease Mouse Model
por: Jeong, Ye Ji, et al.
Publicado: (2021)

Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study
por: Oblak, Adrian L., et al.
Publicado: (2021)

Nothing Iffy about HIF in the Hypothalamus
por: Virtue, Sam, et al.
Publicado: (2011)

Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer’s disease: Alleviation by pantethine
por: van Gijsel-Bonnello, Manuel, et al.
Publicado: (2017)

Sex-Dependent Altered Expression of Cannabinoid Signaling in Hippocampal Astrocytes of the Triple Transgenic Mouse Model of Alzheimer’s Disease: Implications for Controlling Astroglial Activity
por: Pacheco-Sánchez, Beatriz, et al.
Publicado: (2023)

Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer’s disease
por: Sethi, Mansi, et al.
Publicado: (2015)

Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice
por: Griñán-Ferré, Christian, et al.
Publicado: (2016)

Functional and structural connectome properties in the 5XFAD transgenic mouse model of Alzheimer’s disease
por: Kesler, Shelli R., et al.
Publicado: (2018)

Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Lim, Jeremiah K. H., et al.
Publicado: (2020)

Altered Brain Adiponectin Receptor Expression in the 5XFAD Mouse Model of Alzheimer’s Disease
por: Pratap, Anishchal A., et al.
Publicado: (2020)

Myeloperoxidase Deficiency Inhibits Cognitive Decline in the 5XFAD Mouse Model of Alzheimer’s Disease
por: Volkman, Rotem, et al.
Publicado: (2019)

Loss of Hippocampal Calretinin and Parvalbumin Interneurons in the 5XFAD Mouse Model of Alzheimer’s Disease
por: Giesers, Naomi K., et al.
Publicado: (2020)

Retinal Vascular Physiology Biomarkers in a 5XFAD Mouse Model of Alzheimer’s Disease
por: Matei, Nathanael, et al.
Publicado: (2022)

Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer’s Disease
por: Dunham, Sage J. B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o2ube7j3mkd8r8f7n00jts1o29